Zymeworks (ZYME) Shares Outstanding (Diluted Average) (2021 - 2026)

Zymeworks has disclosed Shares Outstanding (Diluted Average) across 6 years of filings, most recently posting $74.7 million for Q1 2026.

• Shares Outstanding (Diluted Average) for Q1 2026 came in at $74.7 million, down 0.71% year-over-year; the trailing twelve-month figure through Mar 2026 was $74.7 million (down 0.71% YoY), and the FY2025 annual result was $75.4 million, down 0.61% from the prior year.
• Shares Outstanding (Diluted Average) came in at $74.7 million for Q1 2026 at Zymeworks, down from $75.4 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $77.4 million in Q2 2025 to a low of $61.4 million in Q1 2022.
• The 5-year median for Shares Outstanding (Diluted Average) is $74.7 million (2026), against an average of $71.4 million.
• Across the five-year window, Shares Outstanding (Diluted Average) gained 27.26% in 2022 and declined 1.34% in 2025, its largest moves.
• Zymeworks' Shares Outstanding (Diluted Average) stood at $65.2 million in 2022, then gained by 5.54% to $68.9 million in 2023, then advanced by 10.19% to $75.9 million in 2024, then decreased by 0.61% to $75.4 million in 2025, then dropped by 0.95% to $74.7 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $74.7 million (Q1 2026), $75.4 million (Q4 2025), and $75.4 million (Q3 2025), per Business Quant data.